These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15320845)

  • 1. A novel therapeutic strategy against vascular disorders with chymase inhibitor.
    Takai S; Miyazaki M
    Curr Vasc Pharmacol; 2003 Jun; 1(2):217-24. PubMed ID: 15320845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of chymase in vascular diseases and the efficacy of chymase inhibitor].
    Takai S
    Nihon Yakurigaku Zasshi; 2003 Aug; 122(2):111-20. PubMed ID: 12890897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chymase inhibitor on vascular proliferation.
    Takai S; Miyazaki M
    Jpn J Pharmacol; 2002 Nov; 90(3):223-7. PubMed ID: 12499576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a chymase inhibitor, NK3201, for prevention of vascular proliferation.
    Takai S; Miyazaki M
    Cardiovasc Drug Rev; 2003; 21(3):185-98. PubMed ID: 12931253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local angiotensin II-generating system in vascular tissues: the roles of chymase.
    Miyazaki M; Takai S
    Hypertens Res; 2001 May; 24(3):189-93. PubMed ID: 11409639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of chymase on vascular proliferation.
    Miyazaki M; Takai S
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):23-6. PubMed ID: 11967791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Chymase in Vascular Proliferation.
    Takai S; Miyazaki M
    Drug News Perspect; 2002 Jun; 15(5):278-282. PubMed ID: 12677223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiological roles of chymase and effects of chymase inhibitor].
    Takai S; Jin D; Miyazaki M
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():41P-47P. PubMed ID: 10629853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation.
    Nishimoto M; Takai S; Kim S; Jin D; Yuda A; Sakaguchi M; Yamada M; Sawada Y; Kondo K; Asada K; Iwao H; Sasaki S; Miyazaki M
    Circulation; 2001 Sep; 104(11):1274-9. PubMed ID: 11551879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of angiotensin II-forming enzymes, angiotensin-converting enzyme and chymase].
    Takai S; Miyazaki M
    Nihon Rinsho; 1999 May; 57(5):1078-83. PubMed ID: 10361438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
    Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
    Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin II formation by chymase in the cardiovascular tissue].
    Okunishi H
    Nihon Yakurigaku Zasshi; 1998 Sep; 112(3):203-12. PubMed ID: 9793075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models.
    Miyazaki M; Takai S; Jin D; Muramatsu M
    Pharmacol Ther; 2006 Dec; 112(3):668-76. PubMed ID: 16837049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis.
    Takai S; Jin D; Muramatsu M; Okamoto Y; Miyazaki M
    Eur J Pharmacol; 2004 Oct; 501(1-3):1-8. PubMed ID: 15464056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
    Liao Y; Husain A
    Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein.
    Takai S; Jin D; Nishimoto M; Yuda A; Sakaguchi M; Kamoshita K; Ishida K; Sukenaga Y; Sasaki S; Miyazaki M
    Life Sci; 2001 Aug; 69(15):1725-32. PubMed ID: 11665834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.
    Li M; Liu K; Michalicek J; Angus JA; Hunt JE; Dell'Italia LJ; Feneley MP; Graham RM; Husain A
    J Clin Invest; 2004 Jul; 114(1):112-20. PubMed ID: 15232618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chymase: a new pharmacologic target in cardiovascular disease.
    Bacani C; Frishman WH
    Cardiol Rev; 2006; 14(4):187-93. PubMed ID: 16788331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase.
    Miyazaki M; Takai S
    J Pharmacol Sci; 2006; 100(5):391-7. PubMed ID: 16799256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery.
    Shiota N; Okunishi H; Takai S; Mikoshiba I; Sakonjo H; Shibata N; Miyazaki M
    Circulation; 1999 Mar; 99(8):1084-90. PubMed ID: 10051304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.